Self-administration with Hizentra means you and your doctor can decide where you can infuse. Convenient dosing routines mean you won't have to adjust or cancel your plans due to IV infusion appointments.
IV infusions can be challenging for people who have hard-to-find or damaged veins. Hizentra allows you to infuse just under the skin, not into a vein, after training from your doctor.
Hizentra has an established safety profile and demonstrated tolerability. In clinical trials, the most common side effects were redness, swelling, itching, and/or bruising at the infusion site; headache; chest, joint or back pain; diarrhea; tiredness; cough; rash; itching; fever, nausea, and vomiting. These are not the only side effects possible.
Hizentra is a prescription medicine used to treat primary immune deficiency (PI) in patients 2 years and older and as maintenance therapy for chronic inflammatory demyelinating polyneuropathy (CIDP) in adults.